Impulse (Qingdao) Health Tech Co.,Ltd. (SHE:002899)
China · Delayed Price · Currency is CNY 19.91
+0.03 (0.15%)
Sep 16, 2026, 3:04 PM CST
SHE:002899 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
| 2,892 | 4,011 | 3,285 | 1,986 | 1,502 | 1,847 | |
Market Cap Growth | -3.83% | 22.08% | 65.43% | 32.19% | -18.65% | 18.20% |
Enterprise Value | 2,931 | 4,024 | 3,225 | 2,210 | 1,621 | 1,526 |
Last Close Price | 19.91 | 27.28 | 22.27 | 16.36 | 12.32 | 15.12 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
PE Ratio | 53.73 | 63.68 | 30.11 | 22.53 | 22.88 | 105.94 |
Forward PE | - | 45.62 | - | - | - | - |
PS Ratio | 2.41 | 3.41 | 2.71 | 2.22 | 1.82 | 2.14 |
PB Ratio | 1.67 | 2.29 | 1.93 | 1.60 | 1.30 | 1.68 |
P/TBV Ratio | 1.75 | 2.40 | 2.03 | 1.72 | 1.40 | 1.83 |
P/FCF Ratio | - | 68.29 | 100.89 | - | - | - |
P/OCF Ratio | 45.03 | 31.75 | 13.84 | 7.64 | 14.39 | 29.69 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.44 | 3.42 | 2.66 | 2.47 | 1.97 | 1.77 |
EV/EBITDA Ratio | 19.21 | 25.69 | 17.79 | 21.63 | 30.72 | 26.22 |
EV/EBIT Ratio | 44.25 | 53.49 | 25.88 | 26.45 | 52.64 | 43.37 |
EV/FCF Ratio | - | 68.52 | 99.05 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.37 | 0.36 | 0.42 | 0.55 | 0.53 | 0.38 |
Debt / EBITDA Ratio | 4.21 | 4.00 | 3.90 | 6.67 | 11.73 | 7.24 |
Debt / FCF Ratio | - | 10.77 | 21.71 | - | - | - |
Net Debt / Equity Ratio | 0.02 | -0.08 | -0.06 | 0.15 | 0.13 | -0.21 |
Net Debt / EBITDA Ratio | 0.26 | -0.87 | -0.53 | 1.84 | 2.78 | -3.89 |
Net Debt / FCF Ratio | -1.01 | -2.33 | -2.95 | -3.94 | -0.42 | 0.61 |
Asset Turnover | 0.42 | 0.41 | 0.46 | 0.41 | 0.43 | 0.55 |
Inventory Turnover | 4.32 | 3.77 | 3.89 | 3.50 | 3.52 | 3.55 |
Quick Ratio | 1.67 | 1.72 | 1.70 | 1.57 | 2.09 | 3.37 |
Current Ratio | 2.14 | 2.13 | 2.10 | 2.07 | 2.70 | 4.28 |
Return on Equity (ROE) | 3.17% | 3.65% | 7.42% | 7.34% | 5.82% | 1.60% |
Return on Assets (ROA) | 1.45% | 1.62% | 2.97% | 2.42% | 1.01% | 1.40% |
Return on Invested Capital (ROIC) | 3.48% | 4.12% | 7.34% | 5.32% | 2.83% | 5.28% |
Return on Capital Employed (ROCE) | 2.90% | 3.30% | 5.40% | 4.50% | 1.80% | 2.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Earnings Yield | 1.90% | 1.57% | 3.32% | 4.44% | 4.37% | 0.94% |
FCF Yield | -1.35% | 1.46% | 0.99% | -2.40% | -23.33% | -20.04% |
Dividend Yield | 0.43% | 0.30% | 0.34% | 0.43% | 0.51% | 0.15% |
Payout Ratio | 53.70% | 46.93% | 36.59% | 41.80% | 38.17% | 74.36% |
Buyback Yield / Dilution | -1.19% | -6.05% | -14.37% | -1.16% | -2.73% | 3.06% |
Total Shareholder Return | -0.76% | -5.75% | -14.03% | -0.72% | -2.22% | 3.21% |